En español
NIDA

Menu

Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Addiction Treatment

Revised June 2012

2002 Meeting Overview:

The Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Addiction Treatment conference was held March 14-15 in New York, New York, and brought together over 800 professionals in the field of drug abuse and addiction studies.  The event was sponsored by the National Institute on Drug Abuse (NIDA) in collaboration with the New York and Long Island nodes of the Clinical Trials Network (CTN), the New York State Office of Alcoholism and Substance Abuse Services, the Northeast Addiction Technology Transfer Centers, the New York State Practice Improvement Collaborative, and the Alcoholism and Substance Abuse Providers of New York State.

The conference included both plenary presentations and workshops led by nationally recognized specialists. Subject matter focused on new developments in research and how to translate findings to community-based settings.  Clinicians and researchers were given the unique opportunity to examine the most up-to-date data on addiction and drug abuse, as well as help determine additional areas of concern in the field.

In his morning address on Day 1, Dr. Glen Hanson discussed major advances in drug addiction research and showed how those findings will help improve drug addiction treatment via a "blending" of practice and research. This was followed by a 2-panel session entitled “Building Bridges Between Practice and Research,” which included discussions regarding NIDA’s Clinical Trials Network (CTN) along with the New York Blending Project. The afternoon Keynote Presentation by Dr. Herbert D. Kleber addressed both advances in substance abuse treatment and obstacles to adequate implementation.  This was followed by a series of 16 concurrent workshops covering a wide range of topics, from Club Drugs to Gender Issues in Substance Abuse.

Day two began with a Plenary session led by Mr. John J. Coppola and Keynote speakers Drs. David Vlahov and Benjy J. Primm.  The remainder of the day was dedicated to 12 additional breakout workshops and a final Plenary session chaired by Drs. Michael Flaherty and Gail Viamonte.

Agendas:

Meeting Day 1

Begin End Session Faculty
8:30 a.m. 9:00 a.m. Welcome and Overview of Conference Timothy P. Condon, Ph.D.
John Rotrosen, M.D.
Edward V. Nunes, M.D.
9:00 a.m. 10:00 a.m. Putting Drug Abuse Research to Use in Real-Life Settings Glen R. Hanson, Ph.D., D.D.S.
10:00 a.m. 10:20 p.m. Break
10:20 a.m. 11:20 p.m. Building Bridges Between Practice and Research
Panel 1: Taking Action Nationally and Locally Plenary Chair: Jack B. Stein, Ph.D.
Betty Tai, Ph.D.
John Rotrosen, M.D.
Richard N. Rosenthal, M.D.
Panel 2: Real-Life Perspectives on Blending Practice and Research Kathleen M. Carroll, Ph.D.
Lawrence S. Brown, Jr., M.D., M.P.H.
11:20 a.m. 12:15 p.m. Break
12:15 p.m. 1:45 p.m. Applying Research in Community Settings Session Chair: Paul Puccio
Keynote Speaker: Herbert D. Kleber, M.D.
1:45 p.m. 3:15 p.m. Concurrent Workshops
Innovations in the Treatment of Adolescent Substance Use Disorders: Blending Research and Practice Chair: Pauls Riggs, M.D.
Andrew R. Morral, Ph.D.
Robert Savitt, M.S.W., CSW
Ramon Solhkhah, M.D.
Early Intervention with At-Risk Children and Adolescents Chair: Stephen J. Donovan, M.D.
John Fitzgerald, CPP
Drew Humphries, Ph.D.
Laurie S. Miller, Ph.D.
Substance Abuse and Infectious Diseases/Medical Consequences of Drug Abuse Chair: Lawrence S. Brown, Jr., M.D., M.P.H.
Don DesJarlais, Ph.D.
Francis A. McCorry, Ph.D.
Susan Tross, Ph.D.
Abuse of Prescription Drugs and Pain Management Chair: Eric Collins, M.D.
Madeline A. Naegle, R.N., Ph.D., CS, FAAN
Sidney H. Schnoll, M.D., Ph.D.
Club Drugs and Methamphetamine Chair: David McDowell, M.D.
Gregory Bunt, M.D.
Perry Halkitis, Ph.D.
Richard Rawson, Ph.D.
Gender Issues Chair: Gloria M. Miele, Ph.D.
Alexis Gadsden, M.S.W., CASAC
S. Lala Ashenberg Straussner, D.S.W., CSW, CEAP, BCD, CAS
Cora Lee Wetherington, Ph.D.
Alternatives to Incarceration Chair: Eileen Pencer, M.S.W., M.Ed., CSD, ACSW
Judge Alex M. Calabrese, J.D.
Jayme A. Delano, CSW
Judge Sol Wachtler
School-Based Interventions Chair: Cynthia Kuhn, Ph.D.
Nancy E. Jones, M.H.S.A., CEAP, CPP
Ellen Morehouse, M.S.W., CASAC
Therapeutic Communities Chair: Robert L. Hubbard, Ph.D., M.B.A.
Allen Bray, M.H.S.
George De Leon, Ph.D.
Kevin McEneaney
Acupuncture for Addiction Treatment Chair: Herbert D. Kleber, M.D.
Vincent Brewington, M.A.
Mindy Fullilove, M.D.
Paul McLaughlin, M.A.
Pregnancy and Maternal and Child Health Chair: Janet Lerner, D.S.W.
Loretta P. Finnegan, M.D.
Angela M. Seracini, Ph.D.
Guiding Treatment in the 21st Century Chair: Susan Brandau
Ira J. Marion, M.A.
Employment Issues in Treatment Outcome Chair: Eileen Wolkstein, Ph.D.
Susan James, Ph.D.
Timothy P. Janikowski, Ph.D.
Alice Ostrowsky, M.A.
Challenges of Blending Clinical Practice and Research Into Daily Program Operations Chair: Robert E. Sage, Ph.D.
Catherine A. Doherty, M.Ed.
Anthony S. Benedetto, CSW, CASAC
Motvational Enhancement Therapy Chair: Jon Morgenstern, Ph.D.
Bruce J. Rounsaville, M.D.
Larry Taub, M.A., CSW
Assessment of Addiction Chair: Deborah Hasin, Ph.D.
Thomas A. Coyne, M.S.W.
3:15 p.m. 3:30 p.m. Break
3:30 p.m. 5:00 p.m. Concurrent Workshops Continued

Meeting Day 2

Begin End Session Faculty
9:00 a.m. 10:15 p.m. Plenary Session Session Chair: John J. Coppola, M.S.W.
Science of Stress and Substance Abuse Keynote Speaker: David Vlahov, Ph.D.
Coping the the Wake of Tragedy Keynote Speaker: Beny J. Primm, M.D.
10:15 a.m. 12:15 p.m. Concurrent Workshops
Assessment for Psychiatric Comorbidity in Addiction Treatment Chair: Edward V. Nunes, M.D.
Kathleen T. Brady, M.D., Ph.D.
Jerome F.X. Carroll, Ph.D.
Jeffrey Selzer, M.D.
Buprenorphine/Naloxone Treatment of Opiate Dependence Chair: Paul P. Casadonte, M.D.
Leslie Amass, Ph.D.
Paul J. Fudala, Ph.D.
Terry Horton
Innovations in Methadone and LAAM Treatment Chair: Mary Jeanne Kreek, M.D.
Ronald Brady, M.D.
Ron Jackson, M.S.W.
Edwin A. Salsitz, M.D.
Smoking Cessation Treatment in Substance Abuse Rehabilitation Programs Chair: Malcolm S. Reid, Ph.D.
Steven Schwartz
Steven Shoptaw, Ph.D.
Family Network Therapy Chair: Marc Galanter, M.D.
Peter Steinglass, M.D.
Jose Szapocznik, Ph.D.
Trauma and Addiction Chair: Denise Hien, Ph.D.
Lisa Najavits, Ph.D.
Nancy J. Smyth, Ph.D., CSW, CASAC
Substance Abuse and Coexisting Disabilities Chair: Kenneth Perez, M.S.
Wayne A. Gordon, Ph.D., ACSW, CASAC
Dennis C. Moore, Ed.D.
How Does the AOD Provider Prepare to Integrate the Use of Addiction Medicines and Clinical Behavioral Treatment? Chair: Steven Kipnis, M.D., FACP
Joy Davidoff, M.P.A.
Treatment of Marijuana Abuse and Dependence Chair: Frances R. Levin, M.D.
Margaret Haney, Ph.D.
Jonathan A. Spears, M.S.W., ACSW
Craving, Addiction, and the Brain: How Can We Apply This to Treatment Chair: Anna Rose Childress, Ph.D.
Steven J. Grant, Ph.D.
Kevin Michael Wadalavage, M.S., CASAC
Naltrexone Revisited Chair: Laura F. McNicholas, M.D., Ph.D.
Sherri Gillette, M.S., CASAC
Jami Rothenberg, Ph.D.
Maria A. Sullivan, M.D., Ph.D.
Motivational Incentives/Contingency Management Chair: Scott Kellogg, Ph.D.
Joseph Krasnansky, CSW
Marion Schwartz, M.S.W., CSW
Maxine Stitzer, Ph.D.
12:15 p.m. 12:30 p.m. Break
12:30 p.m. 2:00 p.m. Plenary Session Chairs: Michael Flaherty, Ph.D.
Gail Viamonte, Ph.D.
Methadone and Beyond: Medication and Its Role in Treating Addiction Mary Jeanne Kreek, M.D.
Where Will We Be in 5 to 10 Years? Mitchell S. Rosenthal, M.D.

 

This page was last updated June 2012

Get this Publication

    National Drug Abuse Treatment Clinical Trials Network: Search listings of drug abuse clinical trials, click here

    Looking for Treatment?

    Use the SAMHSA Treatment Locator or 1-800-662-HELP.